13588-1-AP

antibody from Proteintech Group

Targeting: GZMB CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT

Provider product page for 13588-1-AP

Western blot

ELISA

Immunocytochemistry

Immunohistochemistry

Flow cytometry

Antibody data

Antibody Data
Antigen structure
References [83]
Comments [0]
Validations
Western blot [1]
Immunocytochemistry [1]
Immunohistochemistry [2]

Submit

Product number: 13588-1-AP - Provider product page
Provider: Proteintech Group
Proper citation: Proteintech Cat#13588-1-AP, RRID:AB_2114429
Product name: Granzyme B antibody
Antibody type: Polyclonal
Description: Granzyme B antibody (Cat. #13588-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: FC, IF, IHC, WB,ELISA.
Reactivity: Human
Host: Rabbit
Conjugate: Unconjugated
Isotype: IgG
Vial size: 20ul, 150ul

GZMB protein structure - 13588-1-AP shown in red.

Submitted references DysUFMylation reprograms immunosuppressive neutrophils to potentiate anti-PD-1 therapy in hepatocellular carcinoma.

Gao X, Xu M, Han Z, Hu Z, Su Y, Sun G, Chen W, Qiu S, Qiu S, Hung MC, Zhou C, Yi Y
Cancer letters 2026 May 1;645:218395

DMNQ induces ferroptosis and augments the efficacy of anti-PD-L1 immunotherapy in gastric cancer via the STAT3/SLC1A4 axis to mediate cysteine metabolism reprogramming.

Zhu W, Qi H, Jing F, Shi Y, Xing Y, Ma X, Ning B, Wang Y, Jia Y
Redox biology 2026 Mar;90:104055

Synergistic reprogramming of the tumor immune microenvironment by Senecavirus A and STING agonist.

Zhao X, Gao L, Chen R, Tian H, Liang S, Zhang Z, Li W, Sun J, Chen X, Tang X, Lan T, Sun Y, Ma J
Oncogene 2026 Mar;45(9):809-822

EEPD1 Inhibition Unleashes Antitumor Immunity in Colorectal Cancer by Activating the cGAS-STING Pathway.

Huo L, Wu C, Li X, Ma C, Huang J, Chen Z, He W, Tao T, Zhang W
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026 Mar 30;:e22826

LIFUS-driven engineered bacteria reprogram immunosuppressive niches via mechano-NOTCH signaling.

Lin L, Li X, Guo W, Xie J, Li X, Guan X, Zhao C, Yin H, Xu H
Cell reports. Medicine 2026 Mar 17;7(3):102658

Structural characterization and antitumor activity via immune modulation of an α-glucan from Grifola frondosa.

Tian HX, Ruan QZ, Xie YZ, Chen W, Xiao C, Zhong W, Liu YC, Chen SD, Yong TQ, Hu HP, Li XM, Wu QP
Carbohydrate polymers 2026 Jun 15;382:125254

CD80-Mediated T-Cell Suppression by Cancer Stem-like Cells in Head and Neck Squamous Cell Carcinoma.

Xiao M, Qiu L, Gao Q, Li R, Wang J, Feng Y, Li X, Ge X
Cells 2026 Jan 30;15(3)

Activated T-cell membrane-derived nanocargoes displaying multi-immune checkpoints for enhanced cancer immunotherapy.

Du L, Zhang X, Gong Y, Liu M, Sun J, Hu X, Peng J, Liu Z, Zhang T, Xu J, Gao F, Cheng W
Materials today. Bio 2026 Feb;36:102702

Mutual Exclusion Analysis Shows that DUSP9 Negatively Regulates PD-L1 Expression and Acts as a Target to Enhance Anti-PD-1 Efficacy.

Hu Y, Tang L, Kuang Z, Huang D, Li T, Yin G, Chen Y, Guo W, Han W, Wang P
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026 Feb;13(12):e14347

SREBF2 enhances lipid metabolism and represses anti-tumor immune responses in cervical cancer by increasing ACAT2.

Zhang Y, Shao Y, Li X, Zhou D, Zhou J, Yan Q, Gao W, Yang L
Communications biology 2026 Feb 7;9(1)

Metabolic reprogramming in lacrimal gland GVHD: Stage-specific shifts in acinar cells as drivers of disease progression.

Jin K, Wang N, Mou C, Yuan K, Wang C, Yuan J, Zheng F, Fang Z, Jin X, He J, Wang Q, Yang S
The ocular surface 2026 Apr;40:89-104

KSR2 functions as a metabolic checkpoint for anti-PD-1 resistance by reprogramming glucose metabolism.

Ge Y, Zhou Q, Zhang Q, Hu Y, Wang R
Cancer immunology, immunotherapy : CII 2026 Apr 21;75(5)

A Microbial Lipid-ATP Synthase Axis Fuels NK Cell Antitumor Activity.

Yu K, Sun X, Ma W, Yang J, Sun X, Zhang L, Liu Y, Ren T, Wang Q, Wang J, Li X, Peng X, Yang L, Lv J, Yao Z, Zhang ZS, Wang Q
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026 Apr 13;:e20095

PRMT5-Mediated Arginine Methylation of ACSL4 Attenuates Its Stability and Suppresses Ferroptosis in Renal Cancer.

Zhang M, Liu H, Yin R, Xu J, Fan S, Qian X, Cao M, Li S, Zhang A, Chen G, Yong H, Li Z, Bai J
Research (Washington, D.C.) 2025;8:0789

Identifying the Key Mitochondria-Related Genes in COPD by Integrating Machine Learning and Bioinformatics Analyses.

Qu J, Zhang M, Hu Y, Yang G, Zhang X, Zhang W, Qu Y
International journal of genomics 2025;2025:7060748

Nonshrinkable Thermosensitive Hydrogels Combined with Bispecific Anti-PSMA/CD3 T-Cell Engager for Effective Against Tumors in Mice Model.

Wei PS, Chou PY, Hsu HY, Chen M, Chen YJ, Tsai TH, Wen BY, Sheu MT, Chuang KH, Lin HL
International journal of nanomedicine 2025;20:3083-3111

Development and Validation of an Anoikis-Related Gene Signature for Prognostic Prediction in Cervical Cancer.

Meng S, Li X, Zhang J, Cheng X
International journal of general medicine 2025;18:2861-2879

Targeting PDPN enhances antitumor T-cell activity by disrupting β-catenin-mediated PD-L1 expression in melanoma.

Feng C, Liu Y, Zhong X, Wei Z, Cui H, Yi J
Frontiers in immunology 2025;16:1692864

Engineered NK92 cell-derived exosomes inhibit ovarian cancer progression by degrading GPRC5A.

Si C, Wang Y, Li Y, Chen Y, Fan Y, Wang Y, Tian Y, Gao J, Ma X
Frontiers in immunology 2025;16:1613178

Light-controlled pyroptosis via redox-responsive microneedles enhances photodynamic-epigenetic immunotherapy in breast cancer.

Yu H, Chen Y, Yin J, Yuan Z, Feng S, Duan Y, Yan P, Liu S, Zhu W
Materials today. Bio 2025 Oct;34:102158

HEBP2-governed glutamine competition between tumor and macrophages dictates immunotherapy efficacy in triple-negative breast cancer.

Xiao Y, Xu Y, Wang H, Yang F, Ding XH, Fu T, Chen L, Jin X, Zhao YX, Wang Y, Chen F, Shao ZM, Jiang YZ
Cell metabolism 2025 Oct 7;37(10):2030-2047.e7

Luteolin targets peroxiredoxin 2 to augment T-cell-mediated cytotoxicity and suppress lung adenocarcinoma progression.

Li X, Bai Y, Zhou J, Cheng A, Guo J, Chen M, Hu D, Wu J
European journal of pharmacology 2025 Oct 5;1004:177984

Iron overload-induced ferroptosis in CD8(+) T cells leads to functional abnormalities that promote endometriosis progression.

Wang S, Xu L, Jiao X, Dong X, Zhong Z, Ren Q, Liu X, Yuan M, Wang G
BMC medicine 2025 Oct 27;23(1):588

Glabridin-Gold(I) Complex as a Novel Immunomodulatory Agent Targeting TrxR and MAPK Pathways for Synergistic Enhancement of Antitumor Immunity.

Wang Z, Wang M, Chen Q, Wang M, Li F, Lv L, Wen Z, Xu Z, Yang Y, Bi C, Liu W
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Nov;12(41):e04729

The combination of flaxseed lignans and PD-1/ PD-L1 inhibitor inhibits breast cancer growth via modulating gut microbiome and host immunity.

Wu H, Liu J, Zhang XH, Jin S, Li P, Liu H, Zhao L, Wang J, Zhao S, Tian HD, Lai JR, Hao Y, Liu GR, Hou K, Yan M, Liu SL, Pang D
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2025 May;80:101222

Targeting KMT5C Suppresses Lung Cancer Progression and Enhances the Efficacy of Immunotherapy.

Yuan Y, Li Q, Yan G, Qian Y, Guo W, Li S, Wang F, Shang W, Zhu Z, Ge D, Wang Y, Liu Y
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 May;12(19):e2407575

Multimodal spatial proteomic profiling in acute myeloid leukemia.

Ly CP, Veletic I, Pacheco CD, Dasdemir E, Jelloul FZ, Ferri-Borgogno S, Basi AV, Gomez JA, Root JL, Reville PK, Jindal S, Basu S, Sharma P, Quesada AE, Bueso-Ramos C, Manshouri T, Cuglievan B, Garcia M, Burks JK, Abbas HA
NPJ precision oncology 2025 May 20;9(1):148

Targeting MAPK14 by Lobeline Upregulates Slurp1-Mediated Inhibition of Alternative Activation of TAM and Retards Colorectal Cancer Growth.

Zhao M, Zhou L, Zhang Q, Wang M, Dong Y, Wang Y, Pei R, He E, Liang Y, Shen Y, Deng G, Chen H, Sun D, Shen Y, Sun Y, Cheng H
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Mar;12(10):e2407900

Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors.

Wang X, Fang H, Hu W, Feng Y, Zhou Z, Hu M, Jiang D, Zhang Y, Lan X
Journal of nanobiotechnology 2025 Mar 7;23(1):186

Cryo-trojan mesenchymal stem cells as non-living tumor-homing supercarriers for enhanced drug delivery and immune activation in prostate cancer.

Wang C, Rong X, Zhang F, Mu X, Jiang J
Materials today. Bio 2025 Jun;32:101650

Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer.

Ma D, Dai LJ, Wu XR, Liu CL, Zhao S, Zhang H, Chen L, Xiao Y, Li M, Zhao YZ, Yang L, Zhou T, Li JJ, Yang WT, Jiang YZ, Shao ZM
Cancer cell 2025 Jun 9;43(6):1061-1075.e7

Peptide-based CAR-NK cells: A novel strategy for the treatment of solid tumors.

Wang Q, Yuan X, Liu C, Huang Y, Li L, Zhu Y
Biochemical pharmacology 2025 Feb;232:116741

Itaconate transporter SLC13A3 confers immunotherapy resistance via alkylation-mediated stabilization of PD-L1.

Fan Y, Dan W, Wang Y, Ma Z, Jian Y, Liu T, Li M, Wang Z, Wei Y, Liu B, Ding P, Lei Y, Guo C, Zeng J, Yan X, Wei W, Li L
Cell metabolism 2025 Feb 4;37(2):514-526.e5

ANLN promotes head and neck squamous cell carcinoma progression by upregulating PD-L1 via the ERK-MAPK pathway.

Wang L, Wang J, Wang N, Wang X, Song M, Zhou Y, Wang Z, Meng H, Guo E, Miao S
iScience 2025 Feb 21;28(2):111633

Targeting chaperone-mediated autophagy inhibits properties of glioblastoma stem cells and restores anti-tumor immunity.

Li Y, Sheng M, Li W, Liu S, Wang B, Liu B, Luo M, Zhou X, Xia Q, Hong S, Zheng Z, Cheng SY, Jiang X, Li J, Huang T
Nature communications 2025 Dec 13;17(1):440

Next-generation probiotics Alistipes onderdonkii enhances the efficacy of anti-PD-1 therapy in colorectal cancer.

Xin J, Xiang Y, Jiang J, Jiang Z, Yi B
Biochimica et biophysica acta. Molecular basis of disease 2025 Aug;1871(6):167891

Anti-Her2 CAR-NK92 Cells and Their Exosomes: Generation, Characterization, and Selective Cytotoxicity Against Her2-Positive Tumor Cells.

Tîrziu A, Bojin FM, Gavriliuc OI, Buzan RM, Zbîrcea LE, Grijincu M, Păunescu V
International journal of molecular sciences 2025 Aug 7;26(15)

NAD(+) Metabolism-Mediated SURF4-STING Axis Enhances T-Cell Anti-Tumor Effects in the Ovarian Cancer Microenvironment.

Shen J, Xu F, Liu T, Ye Y, Xu S
Cell death & disease 2025 Aug 23;16(1):640

Granzyme B as a potential biological target in toxic encephalopathy: A big data-based exploratory analysis.

Liu L, Wang J, Liu C
Medicine 2025 Aug 15;104(33):e43879

Overcoming immunotherapy resistance in bladder cancer with a novel antibody-drug conjugate RC48.

Xiao J, Liu J, Zhang C, Liu Z, Nie Z, Yi Z, Gao X, Liang H, Huang J, Cai Z, Yan L, Wu B, Liu Z, Chen J, Zu X, Hu J
Journal for immunotherapy of cancer 2025 Aug 11;13(8)

An Immune Subtype Classification System Enables the Development of Strategies to Predict and Enhance Immunotherapy Responses in Colorectal Cancer.

Li D, Liu X, Gao W, Zhao W, Ji S, Wang S, Yang J, Li D, Chang Z, Chen Y, Sun X, Zhou J, Jiao Y, Du X, Dong G
Cancer research 2025 Apr 15;85(8):1441-1458

Asparagine drives immune evasion in bladder cancer via RIG-I stability and type I IFN signaling.

Wei W, Li H, Tian S, Zhang C, Liu J, Tao W, Cai T, Dong Y, Wang C, Lu D, Ai Y, Zhang W, Wang H, Liu K, Fan Y, Gao Y, Huang Q, Ma X, Wang B, Zhang X, Huang Y
The Journal of clinical investigation 2025 Apr 15;135(8)

Proteogenomic characterization of non-functional pancreatic neuroendocrine tumors unravels clinically relevant subgroups.

Ji S, Cao L, Gao J, Du Y, Ye Z, Lou X, Liu F, Zhang Y, Xu J, Shi X, Wang H, Li P, Li Y, Chen H, Yang Z, Gao S, Zhang W, Huang D, Ni S, Wei M, Wang F, Wang Y, Ding T, Jing D, Fan G, Gong Z, Lu R, Qin Y, Chen J, Xu X, Wang P, Zhang B, Ding L, Robles AI, Rodriguez H, Chang DK, Hruban RH, Gao D, Gao D, Jin G, Zhou H, Wu J, Yu X
Cancer cell 2025 Apr 14;43(4):776-796.e14

The development and potent antitumor efficacy of CD44/CD133 dual-targeting IL7Rα-armored CAR-T cells against glioblastoma.

Zhai Y, Li G, Pan C, Yu M, Hu H, Wang D, Shi Z, Jiang T, Zhang W
Cancer letters 2025 Apr 1;614:217541

The development of anti-PD-1 antibody-induced spinal cord injury in bone marrow transplant C57BL/6 Rag1(-/-) mouse model.

Chen H, Lu Z, Ni X, Zhang H, Chen G, Wu X, Ding M
Immunotherapy 2024;16(14-15):975-985

CD161(+)CD127(+)CD8(+) T cell subsets can predict the efficacy of anti-PD-1 immunotherapy in non-small cell lung cancer with diabetes mellitus.

Qu J, Li Y, Wu B, Shen Q, Chen L, Sun W, Wang B, Ying L, Wu L, Zhou H, Zhou J, Zhou J
Oncoimmunology 2024;13(1):2371575

The peptide-based bispecific CAR T cells target EGFR and tumor stroma for effective cancer therapy.

Liu C, Wang Q, Li L, Gao F, Zhang Y, Zhu Y
International journal of pharmaceutics 2024 Sep 30;663:124558

Xianling Lianxia formula improves the efficacy of trastuzumab by enhancing NK cell-mediated ADCC in HER2-positive BC.

Li F, Shi Y, Ma M, Yang X, Chen X, Xie Y, Liu S
Journal of pharmaceutical analysis 2024 Oct;14(10):100977

The prognostic and therapeutic value of the tumor microenvironment and immune checkpoints in pancreatic neuroendocrine neoplasms.

Chen Z, Lin S, Liang F, Hou Z, Yang Y, Huang H, Pan Y
Scientific reports 2024 Oct 21;14(1):24669

In situ editing of tumour cell membranes induces aggregation and capture of PD-L1 membrane proteins for enhanced cancer immunotherapy.

Mao C, Deng F, Zhu W, Xie L, Wang Y, Li G, Huang X, Wang J, Song Y, Zeng P, He Z, Guo J, Suo Y, Liu Y, Chen Z, Yao M, Zhang L, Shen J
Nature communications 2024 Nov 9;15(1):9723

Antitumor effects of IOX1 combined with bevacizumab-induced apoptosis and immunity on colorectal cancer cells.

Fang S, Cao H, Liu J, Cao G, Li T
International immunopharmacology 2024 Nov 15;141:112896

Overcoming tyrosine kinase inhibitor resistance in lung cancer brain metastasis with CTLA4 blockade.

Fu M, Zhao J, Zhang L, Sheng Z, Li X, Qiu F, Feng Y, You M, Xu H, Zhang J, Zeng R, Huang Y, Li C, Chen W, Chen Z, Peng H, Li L, Wu Y, Ye D, Chi Y, Hua W, Mao Y
Cancer cell 2024 Nov 11;42(11):1882-1897.e7

The construction of modular universal chimeric antigen receptor T (MU-CAR-T) cells by covalent linkage of allogeneic T cells and various antibody fragments.

Chen T, Deng J, Zhang Y, Liu B, Liu R, Zhu Y, Zhou M, Lin Y, Xia B, Lin K, Ma X, Zhang H
Molecular cancer 2024 Mar 11;23(1):53

Picroside II promotes HSC apoptosis and inhibits the cholestatic liver fibrosis in Mdr2(-/-) mice by polarizing M1 macrophages and balancing immune responses.

Jia K, Ma Z, Zhang Y, Xie K, Li J, Wu J, Qu J, Li F, Li X
Chinese journal of natural medicines 2024 Jul;22(7):582-598

Tumorous IRE1α facilitates CD8(+)T cells-dependent anti-tumor immunity and improves immunotherapy efficacy in melanoma.

Yang Y, Wang S, Wang XX, Guo S, Wang H, Shi Q, Tian Y, Wang H, Zhao T, Zhang H, Zhang B, Gao T, Li C, Yi X, Guo W
Cell communication and signaling : CCS 2024 Jan 30;22(1):83

Pumilio1 regulates NPM3/NPM1 axis to promote PD-L1-mediated immune escape in gastric cancer.

Wang H, Zhou Z, Zhang J, Hao T, Wang P, Wu P, Su R, Yang H, Deng G, Chen S, Gu L, He Y, Zeng L, Zhang C, Yin S
Cancer letters 2024 Jan 28;581:216498

Sulforaphane impaired immune checkpoint blockade therapy through activating ΔNP63α/PD-L1 axis in gastric cancer.

Zhang Q, Yang C, Ma Z, Ye L, Wu Y, Zhong C, Shi Y, Zhu M
Molecular carcinogenesis 2024 Aug;63(8):1611-1620

Potential mechanisms of aortic medial degeneration promoted by co-exposure to microplastics and lead.

Xie X, Wang K, Shen X, Li X, Wang S, Yuan S, Li B, Wang Z
Journal of hazardous materials 2024 Aug 15;475:134854

The deubiquitinase USP2a promotes tumor immunosuppression by stabilizing immune checkpoint B7-H4 in lung adenocarcinoma harboring EGFR-activating mutants.

Lu Y, Sun Y, Zhang J, Kong M, Zhao Z, Sun B, Wang Y, Jiang Y, Chen S, Wang C, Tong Y, Wen L, Huang M, Wu F, Zhang L
Cancer letters 2024 Aug 1;596:217020

The SIX1/LDHA Axis Promotes Lactate Accumulation and Leads to NK Cell Dysfunction in Pancreatic Cancer.

Ge W, Meng L, Cao S, Hou C, Zhu X, Huang D, Li Q, Peng Y, Jiang K
Journal of immunology research 2023;2023:6891636

Induction of Tumor Ferroptosis-Dependent Immunity via an Injectable Attractive Pickering Emulsion Gel.

Dai X, Zhang J, Bao X, Guo Y, Jin Y, Yang C, Zhang H, Liu L, Gao Y, Ye C, Wu W, Liu C, Zhao CX, Sheng J, Ren E, Li H, Fang W, Wu B, Ruan J, Gu Z, Chen D, Zhao P
Advanced materials (Deerfield Beach, Fla.) 2023 Sep;35(35):e2303542

Exploring the molecular mechanisms of the involvement of GZMB-Caspase-3-GSDME pathway in the progression of rheumatoid arthritis.

Zhang Y, Cai X, Wang B, Zhang B, Xu Y
Molecular immunology 2023 Sep;161:82-90

Systemic administration of STING agonist promotes myeloid cells maturation and antitumor immunity through regulating hematopoietic stem and progenitor cell fate.

Xu T, Dai J, Tang L, Sun L, Si L, Guo J
Cancer immunology, immunotherapy : CII 2023 Nov;72(11):3491-3505

A novel model associated with tumor microenvironment on predicting prognosis and immunotherapy in triple negative breast cancer.

Zhang J, Zhang M, Tian Q, Yang J
Clinical and experimental medicine 2023 Nov;23(7):3867-3881

Single-cell transcriptomics reveals intestinal cell heterogeneity and identifies Ep300 as a potential therapeutic target in mice with acute liver failure.

Yin J, Zhao Z, Huang J, Xiao Y, Rehmutulla M, Zhang B, Zhang Z, Xiang M, Tong Q, Zhang Y
Cell discovery 2023 Jul 25;9(1):77

Schisandrin B induces HepG2 cells pyroptosis by activating NK cells mediated anti-tumor immunity.

Song A, Ding T, Wei N, Yang J, Ma M, Zheng S, Jin H
Toxicology and applied pharmacology 2023 Aug 1;472:116574

Exploring the effect of polyamines on NK cell function in colorectal cancer process based on glycolysis.

He H, Song Z, Lin S, Wang Y, Wang G
International immunopharmacology 2023 Apr;117:109944

Reforming the Chimeric Antigen Receptor by Peptide Towards Optimized CAR T Cells With Enhanced Anti-Cancer Potency and Safety.

Liu C, Li L, Gao F, Zhou J, Qin Y, Yuan X, Yang G, Zhu Y
Frontiers in bioengineering and biotechnology 2022;10:928169

Biomimetic cell membrane-coated glucose/oxygen-exhausting nanoreactor for remodeling tumor microenvironment in targeted hypoxic tumor therapy.

Guo H, Zhang W, Wang L, Shao Z, Huang X
Biomaterials 2022 Nov;290:121821

B7-H4 is increased in lung adenocarcinoma harboring EGFR-activating mutations and contributes to immunosuppression.

Lu Y, Wu F, Cao Q, Sun Y, Huang M, Xiao J, Zhou B, Zhang L
Oncogene 2022 Jan;41(5):704-717

EZH2 Inhibitor Enhances the STING Agonist‒Induced Antitumor Immunity in Melanoma.

Xu T, Dai J, Tang L, Yang L, Si L, Sheng X, Cui C, Chi Z, Kong Y, Guo J
The Journal of investigative dermatology 2022 Apr;142(4):1158-1170.e8

The Role of Tim-3 on dNK Cells Dysfunction During Abnormal Pregnancy With Toxoplasma gondii Infection.

Li T, Cui L, Xu X, Zhang H, Jiang Y, Ren L, Yang C, Liu X, Hu X
Frontiers in cellular and infection microbiology 2021;11:587150

Development of bispecific anti-c-Met/PD-1 diabodies for the treatment of solid tumors and the effect of c-Met binding affinity on efficacy.

Yuan Q, Liang Q, Sun Z, Yuan X, Hou W, Wang Y, Wang H, Yu M
Oncoimmunology 2021;10(1):1914954

c-Myb facilitates immune escape of esophageal adenocarcinoma cells through the miR-145-5p/SPOP/PD-L1 axis.

Zhang L, Wang X, Li Y, Han J, Gao X, Li S, Wang F
Clinical and translational medicine 2021 Sep;11(9):e464

Inhibition of NLRP3 inflammasome activation in myeloid-derived suppressor cells by andrographolide sulfonate contributes to 5-FU sensitization in mice.

Xu L, Cai P, Li X, Wu X, Gao J, Liu W, Yang J, Xu Q, Guo W, Gu Y
Toxicology and applied pharmacology 2021 Oct 1;428:115672

In situ subcutaneously injectable thermosensitive PEG-PLGA diblock and PLGA-PEG-PLGA triblock copolymer composite as sustained delivery of bispecific anti-CD3 scFv T-cell/anti-EGFR Fab Engager (BiTEE).

Wei PS, Chen YJ, Lin SY, Chuang KH, Sheu MT, Ho HO
Biomaterials 2021 Nov;278:121166

Transcriptome-Based Network Analysis Unveils Eight Immune-Related Genes as Molecular Signatures in the Immunomodulatory Subtype of Triple-Negative Breast Cancer.

Zhang J, Wang L, Xu X, Li X, Guan W, Meng T, Xu G
Frontiers in oncology 2020;10:1787

Apatinib enhanced anti-PD-1 therapy for colon cancer in mice via promoting PD-L1 expression.

Cai X, Wei B, Li L, Chen X, Liu W, Cui J, Lin Y, Sun Y, Xu Q, Guo W, Gu Y
International immunopharmacology 2020 Nov;88:106858

VEGF165b augments NK92 cytolytic activity against human K562 leukemia cells by upregulating the levels of perforin and granzyme B via the VEGR1-PLC pathway.

Wang X, Liang C, Xia W, Guo C, Niu Z, Zhu W, Zhang H
Molecular immunology 2020 Dec;128:41-46

Peptide Blocking of PD-1/PD-L1 Interaction for Cancer Immunotherapy.

Li C, Zhang N, Zhou J, Ding C, Jin Y, Cui X, Pu K, Zhu Y
Cancer immunology research 2018 Feb;6(2):178-188

PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse.

Zheng B, Ren T, Huang Y, Sun K, Wang S, Bao X, Liu K, Guo W
Journal of hematology & oncology 2018 Feb 6;11(1):16

Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features.

Cho YT, Lin JW, Chen YC, Chang CY, Hsiao CH, Chung WH, Chu CY
Journal of the American Academy of Dermatology 2014 Mar;70(3):539-48

Granzyme B is recovered by natural killer cells via clathrin-dependent endocytosis.

Li P, Zheng G, Yang Y, Zhang C, Xiong P, Xu Y, Fang M, Tan Z, Zheng F, Gong F
Cellular and molecular life sciences : CMLS 2010 Sep;67(18):3197-208

No comments: Submit comment

Supportive validation

Submitted by: Proteintech Group (provider)
Main image
Experimental details: HL-60 cells were subjected to SDS PAGE followed by western blot with 13588-1-AP(GZMB antibody) at dilution of 1:500
Sample type: cell line

Supportive validation

Submitted by: Proteintech Group (provider)
Main image
Experimental details: Immunofluorescent analysis of Hela cells, using GZMB antibody 13588-1-AP at 1:50 dilution and Rhodamine-labeled goat anti-rabbit IgG (red). Blue pseudocolor = DAPI (fluorescent DNA dye).
Sample type: cell line

Supportive validation

Submitted by: Proteintech Group (provider)
Main image
Experimental details: Immunohistochemical of paraffin-embedded human lymphoma using 13588-1-AP(GZMB antibody) at dilution of 1:100 (under 10x lens)
Sample type: tissue

Supportive validation

Submitted by: Proteintech Group (provider)
Main image
Experimental details: Immunohistochemical of paraffin-embedded human lymphoma using 13588-1-AP(GZMB antibody) at dilution of 1:100 (under 40x lens)
Sample type: tissue